← Evidence map

ReviewPharmacology & therapeutics2022

Targeting the NLRP3 inflammasome in cardiovascular diseases.

Stefano Toldo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

180 papers cite itlatest 60 shown

2022
…
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34906598